Investigating variations in the AMH signaling pathway related to PCOS
AMH signaling pathway variation in PCOS
This study is looking at how certain genes related to a hormone called anti-Müllerian hormone might affect women with Polycystic Ovary Syndrome (PCOS), with the goal of helping to improve understanding and treatment of this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10818355 on NIH RePORTER |
What this research studies
This research focuses on Polycystic Ovary Syndrome (PCOS), a common condition affecting reproductive-age women that can lead to infertility and other health issues. The study aims to identify genetic variations in the anti-Müllerian hormone (AMH) gene and its receptor, which may contribute to the development and severity of PCOS. By conducting whole genome sequencing, researchers will analyze the impact of these genetic variants on hormone signaling and their potential role as biomarkers for PCOS. This could lead to better understanding and management of the condition for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with Polycystic Ovary Syndrome (PCOS), particularly those experiencing infertility or related metabolic issues.
Not a fit: Patients without a diagnosis of PCOS or those with unrelated reproductive or metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for women with PCOS.
How similar studies have performed: Previous research has shown promise in identifying genetic factors related to PCOS, but this study aims to explore novel genetic variants that have not been extensively tested.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Urbanek, Margrit — Northwestern University at Chicago
- Study coordinator: Urbanek, Margrit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.